RE: Trial websites30 Aug 2020 10:47
Agree gkb47,
They hadn't done pilot data review by 25th August when amended to trial.
"Pivotal phase - estimated at an additional 100 to 300 patients per arm, but the actual number will be determined after the data review at the end of the Pilot phase"
The bottom line is, the trial is being expanded with additional endpoint measures (more data) to get SNG001 fast tracked.
We know there's probably not enough of the last placing funds to carry this out, so I'm expecting a partner to buy in here and using the piggyback to gain the extra shares. IMO
All will be revealed very soon.